{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T01:18:58Z","timestamp":1783214338001,"version":"3.54.6"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7252147"],"award-info":[{"award-number":["7252147"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["BMU2025PYJH015"],"award-info":[{"award-number":["BMU2025PYJH015"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8227010768"],"award-info":[{"award-number":["8227010768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtct.2026.02.060","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T16:14:11Z","timestamp":1772295251000},"page":"889.e1-889.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Donor Characteristics on the Outcomes Following Haploidentical Haematopoietic Stem Cell Transplantation in Patients Aged 55 Yr and Older"],"prefix":"10.1016","volume":"32","author":[{"given":"Wei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.02.060_bib0001","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1158\/1078-0432.CCR-23-3673","article-title":"Improvements in posttransplant outcomes over two decades in older patients with acute myeloid leukemia in the EBMT ALWP study","volume":"30","author":"Bazarbachi","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtct.2026.02.060_bib0002","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41409-023-01925-5","article-title":"Comparison of haploidentical hematopoietic stem cell transplantation with chemotherapy in older adults with acute myeloid leukemia","volume":"58","author":"Sun","year":"2023","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2026.02.060_bib0003","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbmt.2017.09.005","article-title":"Haploidentical transplantation for older patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"24","author":"Ciurea","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.02.060_bib0004","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.stemcr.2020.07.008","article-title":"Clonal hematopoiesis of indeterminate potential as a novel risk factor for donor-derived leukemia","volume":"15","author":"Burns","year":"2020","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jtct.2026.02.060_bib0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1200\/JCO.2018.79.2184","article-title":"Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation","volume":"37","author":"Frick","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jtct.2026.02.060_bib0006","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2017-06-746412","article-title":"Aging of hematopoietic stem cells","volume":"131","author":"de Haan","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.02.060_bib0007","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.02.060_bib0008","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bjh.16303","article-title":"Improved survival after offspring donor transplant compared with older aged-matched siblings for older leukaemia patients","volume":"189","author":"Wang","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2026.02.060_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.758512","article-title":"Haploidentical stem cell transplantation for acute myeloid leukemia: current therapies, challenges and future prospective","volume":"11","author":"Chang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2026.02.060_bib0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbmt.2014.09.021","article-title":"Impact of donor age on outcome after allogeneic hematopoietic cell transplantation","volume":"21","author":"Rezvani","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.02.060_bib0011","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1002\/acg2.42","article-title":"Donor selection for haploidentical hematopoietic cell transplantation-practice guidance","volume":"2","author":"Sun","year":"2019","journal-title":"Adv Cell Gene Ther"},{"key":"10.1016\/j.jtct.2026.02.060_bib0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-016-0265-2","article-title":"How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?","volume":"9","author":"Chang","year":"2016","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2026.02.060_bib0013","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","article-title":"The consensus from the Chinese society of hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update","volume":"14","author":"Zhang X hui","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2026.02.060_bib0014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41409-019-0499-z","article-title":"The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation","volume":"55","author":"Ciurea","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.02.060_bib0015","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","article-title":"Who is the best donor for a related HLA haplotype-mismatched transplant?","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.02.060_bib0016","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbmt.2018.01.013","article-title":"Selecting the best donor for haploidentical transplant: impact of HLA, killer cell immunoglobulin-like receptor genotyping, and other clinical variables","volume":"24","author":"Solomon","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.02.060_bib0017","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2025.288004","article-title":"Age-related differences in donor selection priorities for allogeneic hematopoietic transplantation","author":"Kawamura","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.02.060_bib0018","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT-NIH-CIBMTR task force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.02.060_bib0019","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.02.060_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.02.060_bib0021","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","article-title":"Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia","volume":"108","author":"Cheson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.02.060_bib0022","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1541-0420.2008.00995.x","article-title":"Generalized maximally selected statistics","volume":"64","author":"Hothorn","year":"2008","journal-title":"Biometrics"},{"key":"10.1016\/j.jtct.2026.02.060_bib0023","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.seminhematol.2016.08.001","article-title":"Selecting the best haploidentical donor","volume":"53","author":"McCurdy","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtct.2026.02.060_bib0024","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.bbmt.2014.08.013","article-title":"Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10\/10 human leukocyte antigen-matched unrelated and related donors","volume":"20","author":"Di Stasi","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.02.060_bib0025","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.3324\/haematol.2015.140509","volume":"101","author":"Sun","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.02.060_bib0026","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","article-title":"Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.02.060_bib0027","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s00277-024-05848-z","article-title":"Donor\u2019s age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide \u2013 a single center experience","volume":"103","author":"Zieli\u0144ska","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2026.02.060_bib0028","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ajh.24963","article-title":"Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation","volume":"93","author":"Canaani","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2026.02.060_bib0029","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjh.17978","article-title":"Effect of donor characteristics on T cell-replete haploidentical stem cell transplantation over the last 10\u2009years at a single institution","volume":"196","author":"Wu","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2026.02.060_bib0030","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbmt.2017.09.005","article-title":"Haploidentical transplantation for older patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"24","author":"Ciurea","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.02.060_bib0031","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2017.199","article-title":"Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants","volume":"32","author":"Wang","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2026.02.060_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2025.102346","article-title":"Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients","volume":"16","author":"Jeng","year":"2025","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jtct.2026.02.060_bib0033","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/5584_2025_861","article-title":"The role of aging and senescence in bone marrow transplantation outcome","volume":"1488","author":"Arjmand","year":"2025","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtct.2026.02.060_bib0034","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2016.160804","article-title":"Impact of ABO incompatibility on patients\u2019 outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia \u2013 a report from the Acute Leukemia Working Party of the EBMT","volume":"102","author":"Canaani","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.02.060_bib0035","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41409-017-0016-1","article-title":"Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT","volume":"53","author":"Cesaro","year":"2018","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T01:06:04Z","timestamp":1783213564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672600179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S266663672600179X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.02.060","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Donor Characteristics on the Outcomes Following Haploidentical Haematopoietic Stem Cell Transplantation in Patients Aged 55 Yr and Older","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.02.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}